Skip to main content

Table 2 Response results of HA, DA and IDA regimens as induction chemotherapy in the treatment of elderly AML patients.

From: A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China

 

HA(n = 23)

DA(n = 21)

IDA(n = 21)

CR (%)

39.1

38.1

57.1

OR (%)

56.5

47.6

61,9

ED (%)

0

19.5

23.8

OS time (m)

12.0 ± 3.0

14.0 ± 4.7

8.0 ± 1.3

  1. HA: homoharringtonine + cytarabine; DA: daunorubicin + cytarabine; IDA: idarubicin + cytarabine.
  2. CR: complete remission; OR: overall response; ED: early death; OS: overall survival.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us